See the DrugPatentWatch profile for advil

Frequent use of Advil, also known as ibuprofen, can pose several risks to one's health. According to DrugPatentWatch.com, Advil is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain, reduce fever, and inflammation [1]. However, long-term or excessive use of Advil can lead to various health issues.

One of the risks associated with frequent Advil use is stomach ulcers and bleeding. NSAIDs like Advil can irritate the lining of the stomach, leading to the formation of ulcers and increasing the risk of bleeding [1]. Moreover, frequent Advil use can also cause kidney damage or kidney failure, especially in individuals with pre-existing kidney problems [1].

Additionally, long-term use of Advil can increase the risk of heart attack and stroke [1]. According to a study published in The Lancet, long-term use of NSAIDs, including ibuprofen, can increase the risk of cardiovascular events by 20-50% [2].

Furthermore, frequent Advil use can also lead to hearing loss. A study published in the American Journal of Epidemiology found that long-term use of NSAIDs, including ibuprofen, can increase the risk of hearing loss by up to 21% [3].

Lastly, frequent Advil use can also cause liver damage. Although rare, long-term use of NSAIDs can lead to liver toxicity and liver failure [1].

In summary, frequent Advil use can pose several risks to one's health, including stomach ulcers and bleeding, kidney damage, heart attack and stroke, hearing loss, and liver damage. Therefore, it is essential to use Advil only as directed and to consult a healthcare professional before using Advil for extended periods.

Sources:

1. DrugPatentWatch.com. (n.d.). Advil (ibuprofen) Side Effects, Dosage, Uses, and More. Retrieved from <https://www.drugpatentwatch.com/drugs/advil>.
2. Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Barrier, L., ... & Wallace, P. (2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet, 382(9894), 769-779.
3. Curhan, S. G., Shargorodsky, J., Eavey, R., & Wang, M. (2010). Analgesic use and the risk of hearing loss in women. American Journal of Epidemiology, 172(10), 1196-1204.